The ICMR analysis found that the BPaL regimen is "both more effective and cost-saving" compared to the current standard of ...

Across the spectrum of human afflictions—from cancer to heart disease to rare genetic conditions—medical investigators are continually attempting to break new ground by developing better methods of ...

Antibiotic treatments are losing effectiveness against a range of common bacterial pathogens, including E. coli, K.

UB researchers have developed a new inhalable form of tuberculosis (TB) treatment that could significantly reduce the burden ...

TB disease affects Asian persons more than others.‎ In 2023, TB disease was reported among 2,887 non-Hispanic Asian persons in the United States. This accounts for 30.0% of all people reported with TB ...

In the wake of a recent outbreak of tuberculosis (TB) and latent TB cases at a local San Francisco high school, IGHS's Priya ...

Despite decades of experience, advanced health systems, and deep medical knowledge, the WHO European region is still at risk from the global epidemic of tuberculosis. There are at least three pressing ...

AI-powered digital pathology solution for AFB detection & bacillary grading at scale to support treatment response ...

When India speaks of AI in healthcare, it is not limited to sophisticated algorithms or the promise of precision alone, but ...

The Union Health Ministry has launched an online training programme on AI in healthcare to equip doctors across the country with essential digital co ...

Shorter, six month and alloral treatment regimens for multidrugresistant and rifampicinresistant tuberculosis (MDR/RRTB) are costeffective and deliver better health outcomes than longer regimens.

CureTB referrals showed higher TB treatment completion when patients were linked to care quickly after relocation.